Pelish Henry E.

Chief Scientific Officer · SEC CIK 2029477
Advertisement

Buy track record

How this insider's open-market purchases have performed
This insider has no open-market purchases in the records we parsed, so there's no buy track record to score. Their full filing history is below.
Advertisement
Open-market buys
$0
0 trades
Open-market sells
$12.97M
43 trades
Net flow
−$12.97M
Net selling
Total filings
81
transactions shown

Full transaction history

All Form 4 activity across every company, newest first
View on SEC EDGAR ↗
NUVL
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Oct 15, 2025 ΔOwn −1.3%

Pelish Henry E. sold $74.6K of NUVL, trimming their stake 1%.

−$74.6K
866 sh @ $86
NUVL
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Oct 15, 2025 ΔOwn −0.6%

Pelish Henry E. sold $35K of NUVL, trimming their stake 1%.

−$35K
400 sh @ $87
NUVL
Option exercise Pelish Henry E. · Chief Scientific Officer · Option exercise · filed Oct 15, 2025 ΔOwn +2.5%
+$31.6K
1,669 sh @ $19
NUVL
Option exercise Pelish Henry E. · Chief Scientific Officer · Option exercise · filed Oct 15, 2025 ΔOwn +6.2%
+$116.1K
4,168 sh @ $28
NUVL
Option exercise Pelish Henry E. · Chief Scientific Officer · Option exercise · filed Oct 15, 2025 ΔOwn +2.5%
+$130.2K
1,800 sh @ $72
Advertisement
NUVL
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Oct 15, 2025 ΔOwn −10%

Pelish Henry E. sold $685.9K of NUVL, trimming their stake 10%.

−$685.9K
7,637 sh @ $90
NUVL
Option exercise Pelish Henry E. · Chief Scientific Officer · Option exercise · filed Sep 12, 2025 ΔOwn +1.1%
+$13.8K
731 sh @ $19
NUVL
Option exercise Pelish Henry E. · Chief Scientific Officer · Option exercise · filed Sep 12, 2025 ΔOwn +1.3%
+$24.4K
877 sh @ $28
NUVL
Option exercise Pelish Henry E. · Chief Scientific Officer · Option exercise · filed Sep 12, 2025 ΔOwn +3.1%
+$62.1K
2,117 sh @ $29
NUVL
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Sep 12, 2025 ΔOwn −5.3%

Pelish Henry E. sold $293.6K of NUVL, trimming their stake 5%.

−$293.6K
3,725 sh @ $79
NUVL
Option exercise Pelish Henry E. · Chief Scientific Officer · Option exercise · filed Sep 3, 2025 ΔOwn +3.3%
+$1.7K
2,007 sh @ $1
NUVL
Option exercise Pelish Henry E. · Chief Scientific Officer · Option exercise · filed Sep 3, 2025 ΔOwn +4.8%
+$3.2K
3,000 sh @ $1
NUVL
Option exercise Pelish Henry E. · Chief Scientific Officer · Option exercise · filed Aug 8, 2025 ΔOwn +1.2%
+$13.8K
731 sh @ $19
NUVL
Option exercise Pelish Henry E. · Chief Scientific Officer · Option exercise · filed Aug 8, 2025 ΔOwn +1.4%
+$24.4K
877 sh @ $28
NUVL
Option exercise Pelish Henry E. · Chief Scientific Officer · Option exercise · filed Aug 8, 2025 ΔOwn +6.2%
+$114.2K
3,892 sh @ $29
NUVL
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Aug 8, 2025 ΔOwn −8.3%

Pelish Henry E. sold $411.7K of NUVL, trimming their stake 8%.

−$411.7K
5,500 sh @ $75
NUVL
Option exercise Pelish Henry E. · Chief Scientific Officer · Option exercise · filed Jul 11, 2025 ΔOwn +0.3%
+$3.4K
182 sh @ $19
NUVL
Option exercise Pelish Henry E. · Chief Scientific Officer · Option exercise · filed Jul 11, 2025 ΔOwn +1.4%
+$24.5K
878 sh @ $28
NUVL
Option exercise Pelish Henry E. · Chief Scientific Officer · Option exercise · filed Jul 11, 2025 ΔOwn +7.2%
+$130.2K
4,440 sh @ $29
NUVL
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Jul 11, 2025 ΔOwn −7.9%

Pelish Henry E. sold $420.5K of NUVL, trimming their stake 8%.

−$420.5K
5,260 sh @ $80
NUVL
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Jul 11, 2025 ΔOwn −0.4%

Pelish Henry E. sold $19.4K of NUVL.

−$19.4K
240 sh @ $81
NUVL
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Jul 11, 2025 ΔOwn −3.1%

Pelish Henry E. sold $157.7K of NUVL, trimming their stake 3%.

−$157.7K
1,945 sh @ $81
NUVL
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Jul 11, 2025 ΔOwn −0.3%

Pelish Henry E. sold $16.4K of NUVL.

−$16.4K
200 sh @ $82
NUVL
Option exercise Pelish Henry E. · Chief Scientific Officer · Option exercise · filed Jun 27, 2025 ΔOwn +0.5%
+$9.7K
347 sh @ $28
NUVL
Option exercise Pelish Henry E. · Chief Scientific Officer · Option exercise · filed Jun 27, 2025 ΔOwn +2.9%
+$53.5K
1,823 sh @ $29
NUVL
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Jun 27, 2025 ΔOwn −3.3%

Pelish Henry E. sold $173.4K of NUVL, trimming their stake 3%.

−$173.4K
2,170 sh @ $80
NUVL
Option exercise Pelish Henry E. · Chief Scientific Officer · Option exercise · filed Jun 27, 2025 ΔOwn +5.8%
+$102.4K
3,677 sh @ $28
NUVL
Option exercise Pelish Henry E. · Chief Scientific Officer · Option exercise · filed Jun 27, 2025 ΔOwn +7.4%
+$145.3K
4,953 sh @ $29
NUVL
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Jun 27, 2025 ΔOwn −12%

Pelish Henry E. sold $689.3K of NUVL, trimming their stake 12%.

−$689.3K
8,630 sh @ $80
NUVL
Option exercise Pelish Henry E. · Chief Scientific Officer · Option exercise · filed Jun 10, 2025 ΔOwn +0.2%
+$2.8K
100 sh @ $28

Frequently asked questions

How is Pelish Henry E.'s win rate calculated?

We take every open-market purchase (SEC code P) we can match to a stock price, then compare the split- and dividend-adjusted price on the purchase date to the most recent close. The win rate is the share of those buys currently trading above the purchase price. Sales and share grants are not scored.

Why are some buys not included in the score?

A purchase is excluded if we can't price it — for example if the ticker is missing from the filing, the company has been delisted, or the security isn't a common stock we can match to market data. Excluded counts are shown next to the scored total.

What do the 1M / 3M / 6M / 12M columns mean?

They show each purchase's return after a fixed holding period — one, three, six, and twelve months from the buy date — using split- and dividend-adjusted prices. This separates good entry timing from simply holding a long-running winner. A dash means that horizon hasn't elapsed yet for that trade, or the stock couldn't be priced at that date.

Does a high win rate mean I should copy this insider?

No. Past performance does not predict future results, sample sizes are often small, and an insider's edge in their own company doesn't transfer to yours. This is context, not a recommendation. InsiderSource is not investment advice.

Where does this data come from?

Trades come from Pelish Henry E.'s SEC Form 4 filings on EDGAR. Prices come from public market data and are split/dividend-adjusted. Always verify against the original filings before acting.